Skip to main content
Clinical Trials/CTRI/2023/09/057286
CTRI/2023/09/057286
Not yet recruiting
Phase 2

Prospective interventional study to assess effectiveness of Argentum Nitricum in cases of Irritate Bowel Syndrome - NI

I0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K58- Irritable bowel syndrome
Sponsor
I
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • Pre diagnosed or with clinical presentation of IBS
  • will be randomly selected confirmed with Rome
  • \-All socio economic status

Exclusion Criteria

  • \-Having gross pathological changes
  • \-Suffering from other diseases along with ibs
  • \-Cases with irregular follow ups
  • \-Pregnant and lactating woman
  • \-Severely ill patients who requires immidiate
  • hospitalization

Outcomes

Primary Outcomes

Not specified

Similar Trials